Skip to main content

Featured

Kowloon Central 3D map launched

The Lands Department today launched the 3D Visualisation Map dataset of Kowloon Central and an online application platform Open3Dhk for the public to use free of charge.   To tie in with the development of a smart city, the department started the production of a citywide 3D Visualisation Map in 2021 for release in phases. The first 3D Visualisation Map covering Kowloon East was launched in December 2022.   The Kowloon Central 3D map released today comprises around 9,500 buildings and about 210 individual models of infrastructures, including flyovers, footbridges and subways. It can be downloaded through the Common Spatial Data Infrastructure portal.   Open3Dhk, an online platform transforming a variety of spatial data into user-friendly applications which can support diverse uses by the public, the academia and professionals was also launched today.   Through the interactive functions on the platform, users can view photorealistic 3D city models of Kowloon East and Kowloon Cent
Read more

Testing unaffected by virus mutation

Secretary for Food & Health Prof Sophia Chan today said the reagent used by the Public Health Laboratory Services Branch for COVID-19 testing is not affected by the genetic transformation of the virus’ S protein.   She told legislators the laboratory services branch under the Centre for Health Protection is currently using the polymerase chain reaction (PCR) nucleic acid test to conduct and process COVID-19 testing.   On vaccine procurement, Prof Chan said the vaccines advance purchased by the Government are the inactivated virus vaccine by Sinovac Biotech (Hong Kong), the nucleic acid vaccine by Fosun Pharma/German drug developer BioNTech, and the viral vector vaccine by AstraZeneca/University of Oxford.   The health chief noted the Government’s goal is to procure at least one vaccine from each vaccine technology platform. This means it will purchase four different vaccines, with the aggregate number of doses sufficient to serve at least two times the city’s population.   This is to diversify risks and ensure sufficient supplies of safe and efficacious vaccines for the whole of Hong Kong, Prof Chan added.
http://dlvr.it/RrS93B

Popular Posts